Monday, October 30, 2017 7:09:05 PM
2. buck institute begs to differ. demonstratively helpful to stem cell therapies
3.Fumi Urano begs to differ. Human trial by 2020
4.Funding is dire and critical
5. Maybe he will. He's staying on the field
6. AMBS is owned by its shareholders. Not CHF. Spreading FUD and nonsense
7. I'm hip old man, don't you worry
MANF is a protein in a box
nothing more - nothing less
it is being surpassed by stem cell advances left and right
it is at least 5 - 7 years away from any conceivable human trials whatsoever
and of course, funding appears to be the most dire and critical need - as usual
who knows, maybe Gerald will sell his $130k Tesla and throw those coins in the MANF development bucket
instead of continually sucking AMBS dry
and royally screwing his few remaining loyal shareholders
with lavish travel, high fluting dining, and an unlimited expense account
Oh wiat - that's right
Gerald sold AMBS for $25k to Chang of SeD
so he could now fleece AVDX shareholders
get hip - or get swindled...Brah
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM